1. Home
  2. SEMR vs NVCR Comparison

SEMR vs NVCR Comparison

Compare SEMR & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEMrush Holdings Inc.

SEMR

SEMrush Holdings Inc.

HOLD

Current Price

$11.96

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$10.57

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEMR
NVCR
Founded
2008
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
SEMR
NVCR
Price
$11.96
$10.57
Analyst Decision
Hold
Buy
Analyst Count
5
6
Target Price
$10.00
$28.08
AVG Volume (30 Days)
943.8K
1.0M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
$443,644,000.00
$655,353,000.00
Revenue This Year
$16.85
$7.72
Revenue Next Year
$14.35
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
17.74
8.28
52 Week Low
$6.56
$9.82
52 Week High
$11.96
$20.05

Technical Indicators

Market Signals
Indicator
SEMR
NVCR
Relative Strength Index (RSI) 66.09 38.22
Support Level $11.90 N/A
Resistance Level N/A $14.11
Average True Range (ATR) 0.02 0.56
MACD -0.00 -0.13
Stochastic Oscillator 80.00 13.15

Price Performance

Historical Comparison
SEMR
NVCR

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc offers an online visibility management software-as-a-service (SaaS) platform enabling its clients globally to identify and reach the right audience for their content. The platform utilizes data and intelligence at the core, surrounded by AI-powered interconnected hubs to provide customers with key data, helping them understand trends and derive actionable insights to improve their websites and social media pages, and distribute relevant content to their targeted customers across a variety of digital channels. The company generates nearly all of its revenue from subscriptions to its online visibility management SaaS platform under a SaaS model. Geographically, it generates maximum revenue from the United States, followed by the United Kingdom and other regions.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: